Skip to main content
. Author manuscript; available in PMC: 2018 Jan 24.
Published in final edited form as: Am J Med. 2011 Mar;124(3):235–243. doi: 10.1016/j.amjmed.2010.10.016

Figure 2.

Figure 2

Figure 2

Distribution of treatment by age and geographic region in men with low-risk, intermediate-risk, and high-risk localized prostate cancer, SEER-Medicare 2004–2005. Geographical differences in treatment were significant (p-value <0.001) within each risk group.

* The Western registries were divided into three groups based on similar odds of receiving prostate cancer active therapy vs. conservative management in unadjusted analyses. Group 1: Other West = Utah, Seattle, New Mexico, and Hawaii; Group 2:Los Angeles (LA) and San Francisco (SF); and Group 3: San Jose (SJ) and Greater California (CA)